Migration towards biologic drugs in cancer therapy is encouraging first-in-class innovation in the laryngeal cancer pipeline

throat
Innovation in the pipeline for laryngeal cancer has led to the emergence of five different types of biologics being developed by pharmaceutical companies around the world. Credit: 9nong/Shutterstock.